REVBRevelation Biosciences Inc. Common Stock

1.090USD-1.80%Mkt Cap: 4.34M $P/E: 0.04

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a pro…

Key Statistics

Company
Market Cap4.34M $
Enterprise Value-6.48M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-8.91M $
Revenue/Share
Last Price1.090 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)0.04
P/E (Forward)-0.37
PEG
EV/EBITDA0.58
EV/Revenue
P/S
P/B0.42
EPS (TTM)26.01
EPS (Forward)-2.89
52W Range
0.87502% of range11.72
52W High11.72 USD
52W Low0.8750 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-100.59%
ROA-76.96%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-8.27M $
CapEx (TTM)
FCF Margin
FCF Yield-133.06%
Net Debt-10.74M $
Net Debt/EBITDA0.96
Balance Sheet
Debt/Equity0.08
Current Ratio6.21
Quick Ratio6.11
Book Value/Sh2.576 USD
Cash/Share2.883 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:4
Split DateJan 28, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)19.25 USD
Upside (mean)+1666.1%
Target Range16.00 USD22.50 USD
$16.00+1666.1% to mean$22.50
# Analysts2
Ownership
Shares Out.3.98M
Float3.59M
Insiders4.70%
Institutions12.89%
Short Interest
Short Ratio0.4d
Short % Float0.55%
Short % Out.0.53%
Shares Short20.73K
Short (prev mo.)13.94K
Technical
SMA 501.056 (+3.2%)
SMA 2001.899 (-42.6%)
Beta-0.17
S&P 52W Chg18.16%
Avg Vol (30d)39.61K
Avg Vol (10d)45.07K
Technical Indicators
RSI (14)50.5
MACD0.0140
MACD Signal0.0143
MACD Hist.-0.0003
BB Upper1.200 USD
BB Middle1.079 USD
BB Lower0.9575 USD
BB Width22.49%
ATR (14)0.0749 USD
Vol Ratio (20d)0.30x